Virtual media briefing

18:00 - 19:30 CEST
12:00 - 13:30 EST
Thursday, September 10, 2020


Opening and welcome Dr. Kirhan Ozgurdal, Global Medical Affairs Physician – Oncology, Bayer
Importance of improving survival in patients with unresectable HCC Dr. Catherine Frenette, Scripps Green Hospital, USA
Changing treatment landscape and importance of systemic therapy sequencing Prof. Peter Galle, University Medical Center Mainz, Germany
Effective treatment and management plan to improve survival in HCC Dr. Richard Finn, UCLA Medical Center, USA
Facilitated Q&A Dr. Catherine Frenette, Prof. Richard Finn, Prof. Peter Galle, Prof. Jean-Frédéric Blanc, Le Centre Hospitalier Universitaire de Bordeaux, France
Summary and close Dr. Catherine Frenette
Opportunity for 1:1 interviews with panellists Dr. Catherine Frenette and Dr. Richard Finn, USA Prof. Peter Galle, Germany, Prof. Jean-Frédéric Blanc, France